X
No safety concerns so far in Sangamo’s groundbreaking gene-editing trial
https://pharmaphorum.com/news/no-safety-concerns-far-sangamos-groundbreaking-gene-editing-trial/
advanced therapies
First ever ‘off the shelf’ stem cell therapy nears European approval
Alofisel recommended for complex perianal fistulas in Crohn’s disease
Vericel hopes for US hit with Maci knee treatment
Tissue engineering product previously flopped in EU.
EU regulator wants more advanced therapies
Only a handful of products have reached the market in eight years.